RxDoctor Payments Data

Amber Seeler

Family · Victor, NYNPI 1629644547

Payments from drug & device makers

$10,266in general payments, 2019–2025

Across 539 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Novo Nordisk$955
  • GSK$868
  • Lilly USA, LLC$721
  • plus $3K from 21 others

What the payments were for

  • Food & beverage$10,266100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,266 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$53,291
TrulicityDulaglutide32$37,465
MounjaroTirzepatide27$36,670
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$33,835
JardianceEmpagliflozin14$13,612
EliquisApixaban11$13,042
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$11,905
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl52$9,971
Humalog Kwikpen U-100Insulin Lispro18$3,308
Duloxetine Hcl41$2,113
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,811
Albuterol Sulfate HfaAlbuterol Sulfate57$1,605
Diclofenac Sodium33$835
Gabapentin64$827
Atorvastatin Calcium56$673

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$721$74,13559 claims
Novo NordiskOzempic$955$53,29154 claims
GSKTrelegy Ellipta, Anoro Ellipta$868$45,74050 claims
Boehringer IngelheimJardiance$140$13,61214 claims
PfizerEliquis$1,321$13,04211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in Victor

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →